Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack

Acta Neurologica Scandinavica

Volumn 129, Issue 1, 2014, Pages 41-48

  Chen, P S ^a   Cheng, C L ^b   Kao Yang, Y H ^b   Yeh, P S ^c   Li, Y H ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Ischemic stroke; Statin; Transient ischemic attack

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; TAIWAN; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ISCHEMIC STROKE; STATIN; TRANSIENT ISCHEMIC ATTACK;

ACUTE CORONARY SYNDROME; AGED; ANTICHOLESTEREMIC AGENTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CHOLESTEROL; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; INPATIENTS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; OUTPATIENTS; POLYPHARMACY; TAIWAN; TREATMENT OUTCOME;

EID: 84888860211     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12143     Document Type: Article

References (32)

1. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis - systemic review and up-to-date meta-analysis. Stroke 2004;35:2901-9.
2. Vaughan CJ. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol 2003;91(suppl):23B-9B.
3. Amarenco P, Bogousslavsky J, Callahan A III et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators: high-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.
4. Chan DK, O'Rourke F, Shen Q, Mak JC, Hung WT. Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins. Acta Neurol Scand 2011;124:188-95.
5. Stroke Council, American Heart Association, American Stroke Association. Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association. Stroke 2004;35:1023.
6. Mascitelli L, Pezzetta F. Concerns about efficacy and safety of statins in the prevention of stroke. Intern Med J 2009;39:209-10.
7. Mascitelli L, Pezzetta F, Goldstein MR. Hemorrhagic stroke in the SPARCL study. Stroke 2008;39:e180; author reply e181.
8. Squizzato A, Dentali F, Romualdi E, Ageno W. Statins and secondary prevention of ischemic and hemorrhagic stroke. Stroke 2008;39:e113; author reply e114.
9. Mascitelli L, Pezzetta F, Goldstein MR. Low cholesterol, statin therapy, and intracerebral haemorrhage. Hong Kong Med J 2009;15:403.
10. Hu HH, Sheng WY, Chu FL, Lan CF, Chiang BN. Incidence of stroke in Taiwan. Stroke 1992;23:1237-41.
11. Tanaka H, Ueda Y, Hayashi M et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982;13:62-73.
12. Lakhan SE, Baqchi S, Hofer M. Statins and clinical outcome of acute ischemic stroke: a systemic review. Int Arch Med 2010;3:22.
13. Gomis M, Ois A, Rodriquez-Campello A et al. Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur J Neurol 2010;17:443-8.
14. Meier N, Nedeltchev K, Brekenfeld C et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke 2009;40:1729-37.
15. Bang OY, Saver JL, Liebeskind DS et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007;68:737-42.
16. Kent DM. Stroke-an equal opportunity for the initiation of statin therapy. N Engl J Med 2006;355:613-5.
17. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236-42.
18. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004;35:1941-5.
19. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005;36:1298-300.
20. Montaner J, Chacon P, Krupinski J et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008;15:82-90.
21. Chen J, Zhang ZG, Li Y et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003;53:743-51.
22. Hankey GJ. Impact of treatment of people with transient ischaemic attack on stroke incidence and public health. Cerebrovasc Dis 1996;6(suppl 1):26-33.
23. Johnson SC, Fayad PB, Gorelick PB et al. Prevalence and knowledge of transient ischemic attack among US adults. Neurology 2003;60:1429-34.
24. Kleindorfer D, Panagos P, Pancooli A et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005;36:720-3.
25. Clark TG, Murphy MF, Rothwell PM. Long term risks of stroke, myocardial infarction, and vascular death in "low-risk" patients with a non-recent transient ischemic attack. J Neurol Neurosurg Psychiatry 2003;74:577-80.
26. Makris GC, Lavida A, Nicolaides AN, Geroulakos G. The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins? Atherosclerosis 2010;213:8-20.
27. Collins R, Armitage J, Parish S, Sleight P, Peto R; Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-67.
28. Vergouwen MD, De Haan RJ, Vermeulen M, Roos YB. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008;39:497-502.
29. Kim BJ, Lee SH, Ryu WS, Kang BS, Kim CK, Yoon BW. Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 2009;40:1627-32.
30. Paciaroni M, Agnelli G, Corea F, Ageno W, Caso V, Silvestrelli G. Low levels of low-density lipoprotein cholesterol increase hemorrhagic transformation but not parenchymal hematoma in large artery atherothrombosis. Stroke 2009;40:e544; author reply e545.
31. Alvarez-Sabin J, Huertas R, Quintana M et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007;38:1076-8.
32. Montaner J. Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator-related hemorrhagic transformation. Stroke 2008;39:e6.